HOME >> BIOLOGY >> NEWS
Fox Chase discovery may help physicians diagnose, treat devastating childhood disease

Researchers at Fox Chase Cancer Center have made a crucial discovery that may help physicians better diagnose and treat children with Hirschsprung disease, a debilitating and sometimes life-threatening ailment that causes bowel obstruction and involves an array of genetic changes. The report will be published in the advance online publication of Nature Genetics on May 30.

Developmental biologist Myung K. Shin, Ph.D., and his colleagues have identified a critical regulatory region for the development of the enteric nervous system, which plays a vital role in gastrointestinal functions. Genetic mutations in this region may lead to incomplete development of the enteric nervous system, often causing Hirschsprung disease.

Hirschsprung disease is a hereditary disorder that affects about one in every 5,000 newborns. The disease results from the absence of neural cells, or neurons, in the large intestine, which causes severe bowel obstruction.

So far, the only treatment for this disease is early diagnosis and surgery to remove the diseased segment of the bowel. In general, the prognosis for most children after surgery is very good. However, a significant percentage of patients develop long-term complications or die of complications associated with the disease.

"Currently, ten genes or loci have been linked with Hirschsprung disease," Shin pointed out, "but these mutations do not account for a large percentage of cases."

Shin and his colleagues have isolated a regulatory region affecting the gene for endothelin receptor B (EDNRB), one of the primary genes known to be mutated in Hirschsprung disease "Now it appears that mutations in genomic sequences involved in regulating EDNRB could explain Hirschsprung disease as well," said Shin. "Our results in mice strongly suggest that the regulatory region we've discovered is a prime target for identifying potential regulatory mutations in patients with Hirschsprung disease. These mutations cou
'"/>

Contact: Karen C. Mallet
k_carter@fccc.edu
215-728-2700
Fox Chase Cancer Center
30-May-2004


Page: 1 2 3

Related biology news :

1. Fox Chase Cancer Centers Alfred Knudson Jr. named 2004 Kyoto Prize winner
2. Wilex & Fox Chase Cancer Center begin trial w/ novel compound targeting tumor invasion & metastasis
3. Fox Chase Cancer Center research shows kidney cancer can be diagnosed in urine
4. Fox Chase Cancer Center researchers identify significant smoking-induced genetic alteration
5. Fox Chase Cancer Center research reveals how COX-2 causes ovarian cancer
6. Fox Chase Cancer Center research shows kidney cancer can be diagnosed in urine
7. Fox Chase Cancer Center researcher develops new model for studying prions mad cow disease
8. Fox Chase Cancer Center study: Novel DNA-repair gene mutation can cause resistance to cancer drugs
9. NIH funds Breast Cancer and the Environmental Research Center at Fox Chase Cancer Center
10. Fox Chase Cancer Center researchers make significant discovery about function of p53
11. Fox Chase Cancer Center receives grant to study possible link between measles vaccine and autism

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/22/2018)... ... September 20, 2018 , ... ... founder Adam Slone, proudly announces the successful completion of the Third Annual Life ... America’s only sleepaway tennis camp for underserved youth. The 60 participants are primarily ...
(Date:9/22/2018)... ... September 21, 2018 , ... VTE can present as ... lead to significant morbidity and mortality. VTE affects between 300-600,000 Americans annually, with ... PE is the leading cause of preventable hospital death and maternal mortality. When ...
(Date:9/12/2018)... ... September 11, 2018 , ... ... proud to introduce the new ChemXP™ line of high performance secondary containment coatings, ... was developed to provide Tennant Coatings’ elite certified installers with the needed solutions ...
Breaking Biology News(10 mins):
(Date:8/21/2018)... ... ... The Connecticut Technology Council (CTC) and Marcum LLP today announce the 2018 ... Connecticut. This year’s group of top-ranked companies will be honored at the new ConnectiTECH ... in Hartford. A complete list of the Marcum Tech Top 40 is included below. ...
(Date:8/17/2018)... ... August 16, 2018 , ... KCAS Bioanalytical and Biomarker ... expansion of their team. Dr. Dawn Dufield, Ph.D., joins KCAS as Director of ... LC-MS/MS group that will specialize in developing quantitative LC-MS/MS assays for biopharma molecules. ...
(Date:8/17/2018)... ... August 17, 2018 , ... ... and Environmental Repositories (ISBER) is pleased to announce the release of the Russian ... publication, originally released in January 2018, is a practice-changing publication aimed at advancing ...
(Date:8/14/2018)... ... August 14, 2018 , ... Buprenorphine (BUP) is ... BUP is often prescribed as a sublingual co-formulation with the opioid antagonist naloxone ... participants will learn from a review of the pharmacokinetics of BUP, NBP, and ...
Breaking Biology Technology:
Cached News: